Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.
about
Skin microbiota: a source of disease or defence?High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetasesMicrobiology, genomics, and clinical significance of the Pseudomonas fluorescens species complex, an unappreciated colonizer of humansStructural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetaseDiscovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA SynthetaseFlexibility and communication within the structure of the Mycobacterium smegmatis methionyl-tRNA synthetaseDiscovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative BacteriaBiochemical and phylogenetic analyses of methionyl-tRNA synthetase isolated from a pathogenic microorganism, Mycobacterium tuberculosisBiodiversity of genes encoding anti-microbial traits within plant associated microbesAntimicrobial agents for preventing peritonitis in peritoneal dialysis patientsIn vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations.tRNA synthetase: tRNA aminoacylation and beyondEmergence of resistance during mupirocin treatment: is it a problem in clinical practice?Molecular analysis of methicillin-resistant Staphylococcus aureus as a causative agent of bronchopulmonary infection: relation to colonization in the upper respiratory tract.Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infectionsMupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection.Antibiotic resistance genes detected in the marine sponge Petromica citrina from Brazilian coast.Successful treatment for carriage of methicillin-resistant Staphylococcus aureus and importance of follow-upHorizontal transfer of drug-resistant aminoacyl-transfer-RNA synthetases of anthrax and Gram-positive pathogens.Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use.Enhanced activity of rifalazil in combination with levofloxacin, linezolid, or mupirocin against Staphylococcus aureus in vitro.Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections.Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genes.Antimicrobial peptides and pro-inflammatory cytokines are differentially regulated across epidermal layers following bacterial stimuli.Insights into physiological and genetic mupirocin susceptibility in bifidobacteria.Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureusCharacterization of a conjugative staphylococcal mupirocin resistance plasmidInterpretive criteria for testing susceptibility of staphylococci to mupirocinA postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis.Catalytic enantioselective diversity-oriented synthesis of a small library of polyhydroxylated pyrans inspired from thiomarinol antibiotics.Mechanism of mupirocin transport into sensitive and resistant bacteriaEfficacy of mupirocin in methicillin-resistant Staphylococcus aureus burn wound infectionReview of mupirocin ointment in the treatment of impetigo.Neomycin Sulfate Improves the Antimicrobial Activity of Mupirocin-Based Antibacterial Ointments.MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus.Mupirocin reduces ciliary beat frequency of human nasal epithelial cells.The effect of intraoperative mupirocin irrigation on Staphylococcus aureus within the maxillary sinus.Mupirocin - Are we in danger of losing it?Mupirocin in the Treatment of Staphylococcal Infections in Chronic Rhinosinusitis: A Meta-Analysis.
P2860
Q24651518-49183448-9B6E-42FA-B3D7-1B19721C1A87Q24682048-38BD9EE5-2114-484C-8FDC-6AAC14F0ACF1Q27011525-76871A25-83D2-4CD5-A9A0-622F09F67AD4Q27635179-36410681-9A97-45E0-8A6D-3D386D1EB1A9Q27644677-7AAD97A7-27D6-4F2D-9C92-4EAAAD1C6582Q27664189-BD915806-A256-40E9-8823-7C66BA43F40DQ27675792-7E40C547-E4AE-48F7-9652-83F60094D1A9Q28486961-975E7E11-92DC-4165-BA2A-BB0ED13B851BQ28649879-99F44961-E498-4275-A113-5A075BAB0CD1Q29994654-74BA658C-9A29-4EFB-A7CD-33F24444D1B6Q33311127-DBD39D63-4457-4F18-909D-2C7587280035Q33617931-EB0118A5-CB16-439F-A841-B1987A4BCAD3Q33774299-182FFF91-4DE5-488C-BBC8-992064DD8D11Q33815610-B424502E-EC57-458A-987C-575D9A3B4680Q33970086-DEBF84B1-1DA5-4D62-B1D5-ACFED31CE7D0Q33978627-E1AFF8AC-56EC-46A0-9BE1-22C258CEBEAFQ33980808-BDEB194E-42D0-4B04-8A0A-0466C39CF660Q34046985-206EF8D3-88C9-4077-8155-A4CCE2005C85Q34108643-A45D198C-5D3A-42E8-B945-0D2DE8EB3974Q34250298-187B8ED1-D50C-461E-8648-395231316EF8Q34325146-4ED8CCEF-1AA8-4CBA-AF51-696D78AA5170Q34553464-60BB11C0-BD88-48E7-952F-C14AB5C63693Q34922438-5796B58E-B77F-4684-9032-FC733EA1FB14Q35014019-F6250393-0486-4EA7-AFB2-172EEED5D899Q35015590-5A72635A-5766-4C06-BB47-4BE32C1F7540Q35077244-8A0D72A6-9D10-484F-8EC0-678BF6B5E6CEQ35111075-933662AD-3A89-47E3-A20B-902EE38785E7Q35115167-B042C674-92C3-4983-A991-1D1327ACD5A9Q35136209-3BD67321-22CF-4859-9542-C39623D328D0Q35163364-5B1FE0E6-8DDC-440D-BCC3-547F74B501EEQ35230494-2D385288-7CEB-433D-A403-AEA20C7378A5Q35244108-AB3BD50D-C66A-42CA-B1F0-C99927991DC6Q35344716-9B50BD11-0304-4715-B3A6-15858A5224F9Q35610101-BF0E3FB1-E2E3-40A0-ADA5-C834157DC978Q35848987-92D45D4E-C9EE-4742-BB8D-3F5346C58E64Q35867526-93038529-4E01-4FCF-87FA-11E6CCAA529CQ36061369-8C3585C6-960F-4D30-81D1-A91336D374F7Q36137403-8290B73B-4F86-46C6-B2E6-D3EF6D2FA97DQ36170529-B0CF66DF-92EF-4459-B25A-C8613AB0EFA8Q36210066-DE2FEF75-38B0-49C3-BFF4-9BB67CDB3BEF
P2860
Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.
@en
Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.
@nl
type
label
Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.
@en
Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.
@nl
prefLabel
Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.
@en
Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.
@nl
P2093
P2860
P356
P1476
Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.
@en
P2093
P2860
P304
P356
10.1128/AAC.27.4.495
P407
P577
1985-04-01T00:00:00Z